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Open access under CAmyloid ﬁbrils are commonly observed to adopt multiple distinct morphologies, which eventually can
have signiﬁcantly different neurotoxicities, as e.g. demonstrated in case of the Alzheimer peptide. The
architecture of amyloid deposits is apparently also determined by the stereochemistry of amino acids.
Post-translational changes of the chirality of certain residues may thus be a factor in controlling the for-
mation of functional or disease-related amyloids.
Anionic dermaseptin (aDrs), an unusual peptide from the skin secretions of the frog Pachymedusa
dacnicolor, assembles to amyloid-like ﬁbrils in a pH-dependent manner, which could play a functional
role in defense. aDrs can be enzymatically converted into the diastereomer [D-Leu2]-aDrs by an L/D-isom-
erase. EM and AFM on ﬁbrils formed by these isomers have shown that their predominant morphology is
controlled by the stereochemistry of residue 2, whereas kinetic and thermodynamic parameters of aggre-
gation are barely affected. When ﬁbrils were grown from preformed seeds, backbone stereochemistry
rather than templating-effects apparently dominated the superstructural organization of the isomers.
Interestingly, MD indicated small differences in the conformational propensities between the isomers.
Our results demonstrate how D-amino acid substitutions could take active part in the formation of
functional or disease-related amyloid. Moreover, these ﬁndings contribute to the development of amy-
loid-based nanomaterials.
 2012 Elsevier Inc. Open access under CC BY-NC-ND license. Introduction lecular structures such as amyloid is determined in a decisiveIt is quite evident that the self-assembly of polypeptides to
higher order structures relies on the chiral properties of their
building blocks, the amino acids. This applies accordingly to
amyloid, a highly ordered oligomeric state of polypeptides, which
is characterized by a cross-b sheet structure [1–3]. Several struc-
tures have been proposed, which are consistent with this motif.
In the most simple case, the underlying structure could be
b-sheet tapes, which exhibit a left-handed twist in the ﬁber direc-
tion and perpendicular to the polypeptide strands due to the
L-chirality of naturally occurring amino acids [4]. This example
clearly underscores that the structural organization of supermo-epartment of Biotechnology,
uthgasse 18, A-1190 Vienna,
C BY-NC-ND license. manner by the apparent homochirality of protein biochemistry.
A few cases, however, have been demonstrated where a D-amino
acid is enzymatically incorporated into animal peptides at a well-
deﬁned position [5,6], albeit always close to the termini. To date,
in all vertebrate and several invertebrate peptides the D-amino
acid is the second residue of the mature product. This stereo-
inversion can have drastic consequences on receptor interactions
as e.g. in dermorphins and deltorphins where the all L-forms lack
opioid activity. More subtle differences between the two isomeric
species have been reported for other cases. In particular, in
bombinins H, antimicrobial peptides from the skin of ﬁre-bellied
toads, the D-residue substitution modulates the folding propensity
under conditions, which promote self-aggregation [7,8]. Many
more diastereomeric peptides probably exist, yet may have gone
unnoticed due to the difﬁcult analytics [9,10]. After all, it is a
justiﬁed and interesting question, whether an enzymatically
insertable D-amino acid could have consequences on the
amyloid-like structures formed by natural peptides.
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include the neurodegenerative disorders Alzheimer’s and Parkin-
son’s disease and numerous amyloidoses [1,11–13]. By contrast,
a few cases of diverse functional roles for amyloid in biology have
been shown to date [1,14,15], and most recent results even add
support to the notion of an integrate role of amyloid in innate
immunity [16–24]. In this respect, the antimicrobial activity of
the otherwise disease-associated Ab peptide is worth being men-
tioned [25]. Another example of an amyloid structure involved in
innate immunity may be peptide aDrs2 from the skin of the Mexi-
can tree frog (Pachymedusa dacnicolor), albeit one where the amy-
loid, assembled form is a deposit form rather than the active form
[17]. We suspect that aDrs could also exist in a diastereomeric
form naturally, since the processed N-terminus of aDrs matches
the consensus of a modifying L/D-isomerase and, furthermore, an
aDrs-derived model peptide was positive in our assay [26]; en-
zymes of this kind must be present in the skin secretions as D-ami-
no acid containing peptides (i.e., [Ile2]-deltorphin and dermorphin)
also were observed in this source [27]. Whenever amyloid partici-
pates in physiological processes, the inherent danger of the detri-
mental accumulation of aggregates requires a tight regulation of
its formation [28,29]. It is therefore tempting to speculate that
the D-residue could represent a smart means to control amyloid
formation.
Here, we used aDrs peptide as a model of amyloid generation
with the aim to explore the regulatory potential of an enzymatic
D-amino acid substitution at residue Leu-2. We report the conse-
quences of this D-amino acid substitution on the kinetic and ther-
modynamic parameters of aggregation and the superstructural
organization of the resulting amyloid.Material and methods
Peptide synthesis and preparation of amyloidous gels
All peptides were prepared by solid-phase peptide synthesis
and provided by Peptide Specialty Laboratories (Heidelberg,
Germany). The peptides were puriﬁed by reversed-phase high
performance liquid chromatography (RP-HPLC) using a 0.1% (v/v)
HCl-acetonitrile gradient solvent system. Peptide (monomeric)
stock solutions (10 mg/ml, pH 8.0) were adjusted to pH 3.0 with
a deﬁned volume of diluted HCl and incubated for at least 7 days.
Thioﬂavin T (ThT) assay
ThT stock solution (0.08 % (w/v) ThT in 0.1 N HCl) was added to
peptide samples at the desired pH for ﬂuorescence measurement
(excitation at 440 nm, emission 482 nm, slitwidth 10 nm).
Fourier transform-infra red spectroscopy (FTIR)
Hydrogen exchange of the peptides was performed by repeated
dissolution in D2O and lyophilization at a neutral pD. Peptide sam-
ples were dissolved in DCl/D2O to a ﬁnal concentration of 2 mM
and allowed to aggregate.
All spectra were collected at room temperature on a Bruker
spectrometer (model Tensor 27) as previously described [7]. The
amide I’ region (1600–1700 cm1) of the sample spectrum was
examined [30]. Prior to curve ﬁtting, peaks resulting from water
vapor were interactively removed and a 13-point Savitsky-Golay
smoothing ﬁlter was applied. A straight baseline passing through
the ordinates at 1600 and 1700 cm1 was subtracted. Second-2 Abbreviations used: aDrs, anionic dermaseptin; ThT, thioﬂavin T; PII, polyproline
type II helix.derivative spectra were calculated in order to identify peak posi-
tions. The contributions of the individual peaks were estimated
by ﬁtting Gauss peaks at the most likely band assignments. Sec-
ondary structure was correlated to band frequencies according to
[31].
Transmission electron microscopy (TEM)
Peptide samples were spotted on carbon coated formvar cov-
ered copper grids (Ager Scientiﬁc), negatively stained with 2%
(w/v) uranyl acetate (Electron Microscope Sciences) and examined
with a Jeol 2010 electron microscope operated at 100 kV.
Atomic force microscopy (AFM)[32]
Peptide samples were spotted on freshly cleaved mica, cleaned
silicon wafer (EtOH, H2O) or plasma cleaned carbon coated formvar
covered copper grid and excess sample solution was removed with
ﬁlter paper. AFMmeasurements were performed with a Nanoscope
V multimode (Bruker, Santa Barbara, CA) with a J-scanner (nominal
scan size 130 lm) in Tapping Mode. Measurements in liquid were
performed at room temperature in 5 mM ammoniumacetate
buffer, pH 6.25, or 100 mM NaCl with oxide sharpened silicon
nitrite cantilevers (NP-S, Veeco NanoProbe, USA) with nominal
spring constants of around 0.1 N/m and resonance frequencies
between 14 and 26 kHz. Measurements in air were performed at
room temperature with doped silicon pointprobes (Nanosensors,
Switzerland) with nominal spring constants of 28–76 N/m and
resonance frequencies between 295 and 410 kHz. The samples
were scanned at approximately 1 Hz, the measured scan size
varied from 20 lm to 500 nm. The tapping amplitude during imag-
ing was set to 90% of the free vibrating amplitude of the cantilever.
Polarized light microscopy
Gels (10 mg/ml) were examined for birefringence with a light
microscope (Olympus) under the crossed polarizers of the differen-
tial contrast device using a DPlanApo 40 objective.
Seeding experiments
For the preparation of seeds, preformed gels (10 mg/ml) were
diluted 10-fold into a glass-vial and sonicated in a Elmasonic S
water bath (Elma, Singen, Germany). Alternatively, for the prepara-
tion of seeds consisting of amorphous granules, preformed gels
(10 mg/ml) were adjusted to pH 6.25 with ammoniumacetate
buffer, incubated for 45 min and sonicated brieﬂy, because in
[D-Leu2]-aDrs samples a precipitate was clearly visible at this time.
Monomeric stock solutions (1 mg/ml) were adjusted to pH 3.0 with
a deﬁned volume of diluted HCl and seeds were immediately
added (1/9 of the volume). Samples were incubated for 20 h, which
was deﬁnitely shorter than the lag-period in the absence of seed,
and subjected to TEM or AFM analysis.
Molecular dynamics simulation
The conformational properties of two stereoisomeric peptides
(in the following denoted as LLGD, and LL’GD), which represent
the N-terminal tetrapeptides of aDrs and [D-Leu2]-aDrs, were
investigated by atomistic molecular dynamics (MD) simulation
using the GROMOS11 package of programs [33]. The program
MOE [34] was used to build initial extended-chain structures of
the peptides. The N-terminus and the side chain of residue Asp-4
were protonated (corresponding to a pH value <4), while the
C-terminus was capped with a N-methylamide group. The peptides
were described using the 54A7 force-ﬁeld parameter set, [35] and
Fig. 1. Comparison between peptides aDrs and [D-Leu2]-aDrs. (A) Sequences and enzymatic interconversion. Inverted characters within a sequence denote a D-amino acid. (B)
Overlay of FTIR spectra of amyloidous gels formed by aDrs (dotted line) and [D-Leu2]-aDrs (solid line). (C) Aggregation kinetics of aDrs (j) and [D-Leu2]-aDrs (d). Upon a
decrease in pH, ThT-ﬂuorescence was recorded over time.
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site simple-point-charges water (SPC) model [36]. The systems
were simulated at a constant pressure of 1 atm and a constant tem-
perature of 298.15 K.
The MD trajectories pertaining to production runs of 29.8 ns
length were analyzed with the gromos++ package of programs
[37]. This involved the determination of backbone dihedral angle
probability distributions and the monitoring of intrasolute hydro-
gen bonding. Further details concerning the performed simulations
and analyses are provided in the Supplemental section.Results and discussion
Here, we present our study on the effect of an inversion of back-
bone stereochemistry in the second N-terminal position on the
self-assembly of aDrs peptide (Fig. 1). Thereby diastereomers are
generated; their properties, unlike that of all D-peptides [38–40]
(which represent enantiomers), may differ from those of the parent
peptide. On the other hand, no secondary structure elements areFig. 2. Disaggregation of amyloid in response to a pH-increase. (A) Kinetics of amyloid fo
ThT and after addition of ThT ﬂuorescence was recorded over time upon a decrease in pH
[D-Leu2]-aDrs ﬁbrils coexisting with amorphous aggregates after 1 h incubation without
this time. Scale bar, 100 nm. (C) AFM amplitude error image of [D-Leu2]-aDrs ‘amorpho
striated surface tecture. Sampling size 1.57  1.90 lm.disrupted here as it is, for example, the case in some age-induced
diastereomers of Ab [41,42]. Both aDrs and [D-Leu2]-aDrs assemble
to thioﬂavin T- and congo-red-positive amyloid-like aggregates at
acidic pH (data not shown). Their FTIR spectra are dominated by
a peak with a maximum at 1620 cm1, which is in agreement with
the tight inter-chain hydrogen-bonds characteristic of amyloid. A
close comparison of the FTIR spectra revealed no obvious signiﬁ-
cant differences between the isomers (Fig. 1) and suggested that
variations, if any, do not occur at the bulk secondary structural le-
vel. This outcome was not quite unexpected as the substitution site
is located peripherally and, furthermore, distantly from the aggre-
gation-prone sequence, which is contained within the C-terminal
segment 13-24 (Fig. S1).Kinetic and thermodynamic parameters of aggregation
The kinetics of amyloid formation is commonly characterized
by a lag period. This parameter results from the formation of a
high-energy nucleation core as a prerequisite for ﬁbril growth.rmed by aDrs (j) and [D-Leu2]-aDrs (d). Amyloidous gels were grown in absence of
. Reproducability of the plots was within ±10% (absolute). (B) Negative stain TEM of
ThT at pH 6.25. In control experiments, aDrs ﬁbrils could no longer be observed at
us’ aggregates after 1.5 h incubation without ThT at pH 6.25 in solution reveals a
Fig. 3. Morphological differences between amyloid formed by the aDrs isomers. (A) Negative stain TEM images and (B) AFM amplitude error images predominanly reveal
rope-like ﬁbrils for aDrs amyloidous gel (left panels) and a sheet-like morphology for [D-Leu2]-aDrs (right panels). Height image (B, insert, right panel) of the sheet-like
crystallites reveales a predominant thickness of d = 9 nm, which is consistent with 2 layers of protoﬁlaments. TEM scale bar, 200 nm, insert 2.5. AFM sampling size 2 lm,
insert 2.5 (left panel), and 1 lm, insert 2 (right panel). (C) Polarized light microscopy indicates a different tendency for lateral association into sheet-like crystallites
between aDrs (left panel) and [D-Leu2]-aDrs (right panel).
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speed of ﬁbril growth of aDrs isomers did not reveal any effect of
the D-residue (Fig. 1). Moreover, we determined the so-called crit-
ical concentration (equlibrium concentration of monomer under
dialysis conditions and lowest concentration where ﬁlaments are
observed) to be 5 lM for both isomers. A potential natural strategy
for the regulated formation of functional amyloid would probably
have targeted these parameters. Indeed, several cases of functional
amyloid involve components, which exert unusual lag phases. For
instance, the kinetics of aggregation by fragment rMa of Pmel17, a
major component of mammalian melanosomes, is highly acceler-
ated in comparison to Ab (amyloid b) and proceeds without
obvious lag phase in order to avoid the prolonged presence of toxic
polymerization intermediates [16]. Another example is the trig-
gered ﬁbrillization of CsgA, which for itself has an extraordinary
long lag period and requires CsgB as a nucleator in the biosynthesis
of amyloidous curli [43].More parameters arise from the aDrs-speciﬁc pH-dependent
reversal of aggregation, which, however, is not commonly ob-
served among amyloid species. Thereby, upon a shift in pH to
above pH 5, the amyloid ﬁbrils quickly disassemble in a coopera-
tive manner due to electrostatic repulsion between deprotonated
aspartic acid residues [17]. In the diastereomeric form, the kinetics
of this process is markedly altered (Fig. 2), whereas the transition-
pH remains unaffected by the D-residue (data not shown). In the
course of the ‘melting’ of both aDrs and [D-Leu2]-aDrs, ‘backward’
granular aggregates, 10–500 nm in size, are transiently formed
within the transition interval (pH 5–6.5) (Fig. 2). These have a
residual capability to bind ThT, which is thought to intercalate into
hydrophobic ridges along the ﬁbrils [17]. Therefore, the observed
differences in the base-level ﬂuorescence between the diastereo-
mers also reﬂect different degrees of aligned structures within
those apparently amorphous structures. Indeed, AFM directly
reveals a striated surface texture even in late globular aggregates
Fig. 4. Morphology of amyloid formed by the aDrs isomers cross-seeded with preformed ﬁbrils as revealed by negative stain TEM. Monomeric aDrs solution was brought to
pH 2 and sonicated ﬁbrils from the [D-Leu2]-aDrs sample in Fig. 3 served as parent (left panel), whereas [D-Leu2]-aDrs was seeded with aDrs ﬁbrils (right panel). Scale bar,
200 nm.
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metastable amorphous structures do not have the capability to
seed ﬁbril formation, which is a clear argument against a possible
amyloidic nature. Interestingly, these aggregates are highly cyto-
toxic and thus can serve as an agent against eukaryotic offenders
as active components of the innate immune system.
Morphological differences between isomers
Furthermore, morphological differences were obviously present
between higher order structures formed by the different isomers.
The predominant morphology for aDrs were rope-like ﬁbrils with
a periodic twist of h = 330 nm built up by protoﬁlaments of
a = 4.5 nm. By contrast, [D-Leu2]-aDrs exclusively formed sheet-
like stacks of protoﬁlaments with no explicit twist (Fig. 3). AFM re-
vealed a predominant thickness of d = 9 nm for these stacks, which
is consistent with two layers of protoﬁlaments. We never observed
rope-like structures in [D-Leu2]-aDrs samples. This fundamental
difference in superstructural organization, in particular the differ-
ent tendency to associate laterally into aligned ﬁlamentous multi-
mers (crystallites), is also reﬂected in the microscopic appearance
under linearly polarized light (as depicted in Fig. 3). Consistently,
the [D-Leu2]-aDrs samples were characterized by a high content
of large crystallites.
Polymorphism phenomena seem to be a frequent attribute of
amyloid-forming peptides and switching between different super-
structures is frequently observed [44]. Ab(1–40), for example,
predominantly forms either ﬁbrils with a periodic twist (50- to
200-nm period) or ﬁlaments with no resolvable twist but laterally
associated to dimers or multimers in dependence of whether
mechanical stress is applied [45]. A similar behavior has been
described for the insulin B-chain [46] and other peptides [44]. Most
interestingly, different mature ﬁbril morphologies may result in
different neurotoxic properties, a ﬁnding of general importance
with far-ranging implications. In particular, the toxicity of ‘‘quies-
cent’’ Ab(1–40) rope-like ﬁbrils was reported to be signiﬁcantly
higher than that of the agitated untwisted species [45]. Inconve-
niently, the pH-instability of aDrs ﬁbrils prevented an experimen-
tal investigation in this case.
Inheritance of superstructure morphologies
Next we were interested to see whether the respective super-
structure morphologies would be inheritable as it is observed forseveral amyloids and prion strains [44,45,47,48]. Seeding of aDrs
or [D-Leu2]-aDrs with preformed ﬁbrils of either morphology
diminished the lag period by obviously acting as nucleators. No
gels were formed in control experiments without seeds. Further-
more, aDrs peptide could act as nucleator for the polymerization
of [D-Leu2]-aDrs, and vice versa. The morphology, however, was
not inherited to the daughter superstructures under our experi-
mental conditions, which were largely dictated by the pH-proﬁle
of ﬁbrillation (Fig. 4). Instead, the stereochemistry of the mono-
mers apparently determined the predominant morphology. This
fact indicates that in this case the inherent thermodynamic prefer-
ence cannot be overcome by templating as opposed to by inheri-
tance effects observed for other peptides such as Ab(1–40) [45].
These are apparently less determined in the selection of the super-
structures and do inherit their morphology. Nevertheless, the poly-
morphism of Ab(1–40) superstructures is due to, or at least
accompanied by, structural differences at the molecular level as
evidenced by solid-state NMR [45]. Noteworthy, Ab(1–40) contains
several Glys throughout the sequence. Gly can, as a matter of fact,
rather freely assume U, W values typical of both L- and D-amino
acids [49]. In the enkephalins, for example, Glys can indeed substi-
tute for the D-residue present in the frog opioid peptides. We were
therefore interested to see whether in the aDrs system a certain
superstructure could be stereochemically ‘locked in’ by the com-
plementary rotamers of the bulky Leu-2 enantiomers. In the MD
simulations in explicit water, the backbone conformational distri-
butions p(U) and p(W) of the stereoisomeric N-terminal tetrapep-
tides LLGD and LL’GD were found to be rather similar, except for
small differences in peak heights for p(U) of residue Gly-3, as well
as peak positions and heights for p(W) of residue Asp-4 (Fig. S4). In
both peptides, theU-torsion of the latter residue sampled predom-
inantly conformational ensembles indicative of b-strand like
(shoulder at 243) or PII-like (peak at 291) secondary structure
motives. However, the W-torsion of residue Asp-4 revealed pre-
dominantly conformational ensembles indicative of b-strand like
conformations (peak at 132) for peptide LLGD, or PII-like (peak
at 149) secondary structure motives in peptide LL’GD (Fig. 5).
Moreover, the simulation of peptide LLGD presented a backbone
hydrogen bond between residues Asp-4 (backbone amide hydro-
gen atom) and Leu-2 (backbone carbonyl oxygen atom) with an
occurrence of 15.1%, while this hydrogen bond occurred in only
6.3% of the simulation of peptide LL’GD. The relevance of these
ﬁndings, which were derived from a simulated water environment,
for the higher-order superstructures formed by the peptides in
Fig. 5. Structures fromMD simulation of the tetrapeptide H3N+–Leu–Leu–Gly–Asp–NH–CH3 with residue Leu-2 either in the L- (left structure) or D- (right structure) form. The
structures are representatives of conformational differences between the two peptides as observed in the sampled conﬁgurational ensembles. The all-L structure corresponds
to a trajectory frame sampled at 12.024 ns and shows backbone hydrogen bonding between residues Asp-4 (backbone amide hydrogen atom) and Leu-2 (backbone carbonyl
oxygen atom). The [D-Leu2]-stereoisomer corresponds to a trajectory frame sampled at 12.720 ns and shows PII-like backbone torsions for residue Asp-4. Figures were
generated using the pymol program [55].
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fact that polyproline type II helices are also suspected to be of
importance in amyloidogenesis [50]. Further simulations will be
necessary to show whether it is indeed the conformation of the
N-terminal segment, which crucially affects ﬁbril twist and thus
the resulting superstructure.
It is an interesting fact that several other natural aggregation-
prone peptides are candidates for a stereoisomerization by a
L/D-isomerase, of which genes are present throughout the species
up to man. These include the insulin B-chain and, most interest-
ingly, ovCNP, a C-type II member of the natriuretic peptide-family
from the venom of male platypus, a primitive mammal [51], for
which the existence of the diastereomeric form has been experi-
mentally demonstrated [52]. CNP is situated in the context of atrial
amyloidosis and explicitly shares with several other amyloidogenic
peptides the ability to assemble to ion-selective pores within bilay-
ers [53]. The role of the D-residue in any of these processes is how-
ever unclear.
Conclusion
Our study on the effect of a stereochemical modiﬁcation on aDrs
aggregation revealed interesting aspects of superstructural organi-
zation and polymorphism, which is in the focus of current research.
In fact, this modiﬁcation results in a fundamental change in super-
structural organization, which is particularly remarkable consider-
ing that the site of stereoinversion is not localized within the
aggregation-prone sequence and, furthermore, this modiﬁcation
can be enzymatically introduced. Therefore, our results could not
only contribute to the understanding of natural strategies to con-
trol protein aggregation in cases where amyloid with its unique
properties is a functional, integrated component of the organism,
but also could provide conceptual clues about the pathogenesis
of protein deposition disorders, i.e., certain neurodegenerative dis-
eases or amyloidoses. There, the differential toxicity of superstruc-
ture morphologies is certainly important, and cross-seeding effects
are thought to be crucially involved in the complex development of
such pathological states [54]. Moreover, a superstructural switch
might be a valuable feature when implemented into amyloid-
based nanomaterials.
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